MSR93 Assessing Similarity of Studies for Network Meta-Analysis: The Use of Feasibility Assessment and Sensitivity Analyses to Estimate the Efficacy of Tirbanibulin, a New Drug for Actinic Keratosis
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1824
https://www.valueinhealthjournal.com/article/S1098-3015(22)04029-3/fulltext
Title :
MSR93 Assessing Similarity of Studies for Network Meta-Analysis: The Use of Feasibility Assessment and Sensitivity Analyses to Estimate the Efficacy of Tirbanibulin, a New Drug for Actinic Keratosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04029-3&doi=10.1016/j.jval.2022.09.1824
First page :
Section Title :
Open access? :
No
Section Order :
11372